CD209 and COVID-19: Furthermore, pDCs showed a notable increase in CD209 in BALF with accompanying depletion in sera in mild, but not severe, cases, and therefore chemokine homing ligands would reflect the migration changes of pDC from blood to lung in mild and severe COVID-19 [303].